These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32445758)

  • 1. Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model.
    Li T; Tu L; Gu R; Yang XL; Liu XJ; Zhang GP; Wang Q; Ren YP; Wang BJ; Tian JY
    Life Sci; 2020 Sep; 256():117824. PubMed ID: 32445758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J; Sharma MK; Gengler S; Hölscher C
    Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease.
    Zhang L; Zhang L; Li Y; Li L; Melchiorsen JU; Rosenkilde M; Hölscher C
    J Parkinsons Dis; 2020; 10(2):523-542. PubMed ID: 31958096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C
    Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
    Shi L; Zhang Z; Li L; Hölscher C
    Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two novel dual GLP-1/GIP receptor agonists are neuroprotective in the MPTP mouse model of Parkinson's disease.
    Feng P; Zhang X; Li D; Ji C; Yuan Z; Wang R; Xue G; Li G; Hölscher C
    Neuropharmacology; 2018 May; 133():385-394. PubMed ID: 29462693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
    Salles GN; Calió ML; Hölscher C; Pacheco-Soares C; Porcionatto M; Lobo AO
    Neuropharmacology; 2020 Jan; 162():107813. PubMed ID: 31628935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel dual-glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist is neuroprotective in transient focal cerebral ischemia in the rat.
    Han L; Hölscher C; Xue GF; Li G; Li D
    Neuroreport; 2016 Jan; 27(1):23-32. PubMed ID: 26555034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
    Jalewa J; Sharma MK; Hölscher C
    J Neurochem; 2016 Oct; 139(1):55-67. PubMed ID: 27412483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC79, a novel Akt activator, protects dopaminergic neuronal cells from MPP
    Zhu JL; Wu YY; Wu D; Luo WF; Zhang ZQ; Liu CF
    Mol Cell Biochem; 2019 Nov; 461(1-2):81-89. PubMed ID: 31342299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.
    Cao L; Li D; Feng P; Li L; Xue GF; Li G; Hölscher C
    Neuroreport; 2016 Apr; 27(6):384-91. PubMed ID: 26918675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.
    Zhang Q; Zhang J; Jiang C; Qin J; Ke K; Ding F
    Neuroscience; 2014 Jun; 270():183-91. PubMed ID: 24755484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naringin Exhibits Neuroprotection Against Rotenone-Induced Neurotoxicity in Experimental Rodents.
    Garabadu D; Agrawal N
    Neuromolecular Med; 2020 Jun; 22(2):314-330. PubMed ID: 31916219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel GLP-1/GIP dual receptor agonist DA3-CH is neuroprotective in the pilocarpine-induced epileptogenesis rat model.
    Tian MJ; Wang RF; Hölscher C; Mi RL; Yuan ZY; Li DF; Xue GF
    Epilepsy Res; 2019 Aug; 154():97-106. PubMed ID: 31121474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin protects MES23.5 cells against rotenone via inhibiting mitochondrial dysfunction and apoptosis.
    Yu J; Xu H; Shen X; Jiang H
    Neuropeptides; 2016 Apr; 56():69-74. PubMed ID: 26459609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
    Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
    Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
    Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H
    Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.